The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global GMP Plasmid DNA Market Research Report 2025
Synopsis
GMP plasmid DNA, or GMP Grade Plasmid DNA can be used for direct injection as DNA vaccines, gene therapy, or ex-vivo applications such as cell and gene therapies. Compare with other Plasmid DNA, GMP Plasmid has no animal derived enzymes or organic solvents.
The global GMP Plasmid DNA market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for GMP Plasmid DNA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for GMP Plasmid DNA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for GMP Plasmid DNA in DNA Vaccines is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of GMP Plasmid DNA include Cobra Bio, Waisman Biomanufacturing, Gedeon Richter, Eurogentec, VGXI, PlasmidFactory, Kaneka, Delphi Genetics and Nature Technology Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GMP Plasmid DNA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Plasmid DNA.
Report Scope
The GMP Plasmid DNA market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GMP Plasmid DNA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Plasmid DNA companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cobra Bio
Waisman Biomanufacturing
Gedeon Richter
Eurogentec
VGXI
PlasmidFactory
Kaneka
Delphi Genetics
Nature Technology Corporation
LakePharma
Segment by Type
Standard
Ultra-Pure
Segment by Application
DNA Vaccines
Gene Therapy
Immunotherapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Plasmid DNA companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
GMP plasmid DNA, or GMP Grade Plasmid DNA can be used for direct injection as DNA vaccines, gene therapy, or ex-vivo applications such as cell and gene therapies. Compare with other Plasmid DNA, GMP Plasmid has no animal derived enzymes or organic solvents.
The global GMP Plasmid DNA market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for GMP Plasmid DNA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for GMP Plasmid DNA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for GMP Plasmid DNA in DNA Vaccines is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of GMP Plasmid DNA include Cobra Bio, Waisman Biomanufacturing, Gedeon Richter, Eurogentec, VGXI, PlasmidFactory, Kaneka, Delphi Genetics and Nature Technology Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GMP Plasmid DNA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Plasmid DNA.
Report Scope
The GMP Plasmid DNA market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GMP Plasmid DNA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Plasmid DNA companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cobra Bio
Waisman Biomanufacturing
Gedeon Richter
Eurogentec
VGXI
PlasmidFactory
Kaneka
Delphi Genetics
Nature Technology Corporation
LakePharma
Segment by Type
Standard
Ultra-Pure
Segment by Application
DNA Vaccines
Gene Therapy
Immunotherapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Plasmid DNA companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GMP Plasmid DNA Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Standard
1.2.3 Ultra-Pure
1.3 Market by Application
1.3.1 Global GMP Plasmid DNA Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 DNA Vaccines
1.3.3 Gene Therapy
1.3.4 Immunotherapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global GMP Plasmid DNA Market Perspective (2019-2030)
2.2 GMP Plasmid DNA Growth Trends by Region
2.2.1 Global GMP Plasmid DNA Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 GMP Plasmid DNA Historic Market Size by Region (2019-2024)
2.2.3 GMP Plasmid DNA Forecasted Market Size by Region (2025-2030)
2.3 GMP Plasmid DNA Market Dynamics
2.3.1 GMP Plasmid DNA Industry Trends
2.3.2 GMP Plasmid DNA Market Drivers
2.3.3 GMP Plasmid DNA Market Challenges
2.3.4 GMP Plasmid DNA Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GMP Plasmid DNA Players by Revenue
3.1.1 Global Top GMP Plasmid DNA Players by Revenue (2019-2024)
3.1.2 Global GMP Plasmid DNA Revenue Market Share by Players (2019-2024)
3.2 Global GMP Plasmid DNA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by GMP Plasmid DNA Revenue
3.4 Global GMP Plasmid DNA Market Concentration Ratio
3.4.1 Global GMP Plasmid DNA Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GMP Plasmid DNA Revenue in 2023
3.5 GMP Plasmid DNA Key Players Head office and Area Served
3.6 Key Players GMP Plasmid DNA Product Solution and Service
3.7 Date of Enter into GMP Plasmid DNA Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GMP Plasmid DNA Breakdown Data by Type
4.1 Global GMP Plasmid DNA Historic Market Size by Type (2019-2024)
4.2 Global GMP Plasmid DNA Forecasted Market Size by Type (2025-2030)
5 GMP Plasmid DNA Breakdown Data by Application
5.1 Global GMP Plasmid DNA Historic Market Size by Application (2019-2024)
5.2 Global GMP Plasmid DNA Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America GMP Plasmid DNA Market Size (2019-2030)
6.2 North America GMP Plasmid DNA Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America GMP Plasmid DNA Market Size by Country (2019-2024)
6.4 North America GMP Plasmid DNA Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GMP Plasmid DNA Market Size (2019-2030)
7.2 Europe GMP Plasmid DNA Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe GMP Plasmid DNA Market Size by Country (2019-2024)
7.4 Europe GMP Plasmid DNA Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GMP Plasmid DNA Market Size (2019-2030)
8.2 Asia-Pacific GMP Plasmid DNA Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific GMP Plasmid DNA Market Size by Region (2019-2024)
8.4 Asia-Pacific GMP Plasmid DNA Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GMP Plasmid DNA Market Size (2019-2030)
9.2 Latin America GMP Plasmid DNA Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America GMP Plasmid DNA Market Size by Country (2019-2024)
9.4 Latin America GMP Plasmid DNA Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GMP Plasmid DNA Market Size (2019-2030)
10.2 Middle East & Africa GMP Plasmid DNA Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa GMP Plasmid DNA Market Size by Country (2019-2024)
10.4 Middle East & Africa GMP Plasmid DNA Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cobra Bio
11.1.1 Cobra Bio Company Detail
11.1.2 Cobra Bio Business Overview
11.1.3 Cobra Bio GMP Plasmid DNA Introduction
11.1.4 Cobra Bio Revenue in GMP Plasmid DNA Business (2019-2024)
11.1.5 Cobra Bio Recent Development
11.2 Waisman Biomanufacturing
11.2.1 Waisman Biomanufacturing Company Detail
11.2.2 Waisman Biomanufacturing Business Overview
11.2.3 Waisman Biomanufacturing GMP Plasmid DNA Introduction
11.2.4 Waisman Biomanufacturing Revenue in GMP Plasmid DNA Business (2019-2024)
11.2.5 Waisman Biomanufacturing Recent Development
11.3 Gedeon Richter
11.3.1 Gedeon Richter Company Detail
11.3.2 Gedeon Richter Business Overview
11.3.3 Gedeon Richter GMP Plasmid DNA Introduction
11.3.4 Gedeon Richter Revenue in GMP Plasmid DNA Business (2019-2024)
11.3.5 Gedeon Richter Recent Development
11.4 Eurogentec
11.4.1 Eurogentec Company Detail
11.4.2 Eurogentec Business Overview
11.4.3 Eurogentec GMP Plasmid DNA Introduction
11.4.4 Eurogentec Revenue in GMP Plasmid DNA Business (2019-2024)
11.4.5 Eurogentec Recent Development
11.5 VGXI
11.5.1 VGXI Company Detail
11.5.2 VGXI Business Overview
11.5.3 VGXI GMP Plasmid DNA Introduction
11.5.4 VGXI Revenue in GMP Plasmid DNA Business (2019-2024)
11.5.5 VGXI Recent Development
11.6 PlasmidFactory
11.6.1 PlasmidFactory Company Detail
11.6.2 PlasmidFactory Business Overview
11.6.3 PlasmidFactory GMP Plasmid DNA Introduction
11.6.4 PlasmidFactory Revenue in GMP Plasmid DNA Business (2019-2024)
11.6.5 PlasmidFactory Recent Development
11.7 Kaneka
11.7.1 Kaneka Company Detail
11.7.2 Kaneka Business Overview
11.7.3 Kaneka GMP Plasmid DNA Introduction
11.7.4 Kaneka Revenue in GMP Plasmid DNA Business (2019-2024)
11.7.5 Kaneka Recent Development
11.8 Delphi Genetics
11.8.1 Delphi Genetics Company Detail
11.8.2 Delphi Genetics Business Overview
11.8.3 Delphi Genetics GMP Plasmid DNA Introduction
11.8.4 Delphi Genetics Revenue in GMP Plasmid DNA Business (2019-2024)
11.8.5 Delphi Genetics Recent Development
11.9 Nature Technology Corporation
11.9.1 Nature Technology Corporation Company Detail
11.9.2 Nature Technology Corporation Business Overview
11.9.3 Nature Technology Corporation GMP Plasmid DNA Introduction
11.9.4 Nature Technology Corporation Revenue in GMP Plasmid DNA Business (2019-2024)
11.9.5 Nature Technology Corporation Recent Development
11.10 LakePharma
11.10.1 LakePharma Company Detail
11.10.2 LakePharma Business Overview
11.10.3 LakePharma GMP Plasmid DNA Introduction
11.10.4 LakePharma Revenue in GMP Plasmid DNA Business (2019-2024)
11.10.5 LakePharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global GMP Plasmid DNA Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Standard
Table 3. Key Players of Ultra-Pure
Table 4. Global GMP Plasmid DNA Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global GMP Plasmid DNA Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global GMP Plasmid DNA Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global GMP Plasmid DNA Market Share by Region (2019-2024)
Table 8. Global GMP Plasmid DNA Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global GMP Plasmid DNA Market Share by Region (2025-2030)
Table 10. GMP Plasmid DNA Market Trends
Table 11. GMP Plasmid DNA Market Drivers
Table 12. GMP Plasmid DNA Market Challenges
Table 13. GMP Plasmid DNA Market Restraints
Table 14. Global GMP Plasmid DNA Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global GMP Plasmid DNA Market Share by Players (2019-2024)
Table 16. Global Top GMP Plasmid DNA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Plasmid DNA as of 2023)
Table 17. Ranking of Global Top GMP Plasmid DNA Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by GMP Plasmid DNA Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players GMP Plasmid DNA Product Solution and Service
Table 21. Date of Enter into GMP Plasmid DNA Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global GMP Plasmid DNA Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global GMP Plasmid DNA Revenue Market Share by Type (2019-2024)
Table 25. Global GMP Plasmid DNA Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global GMP Plasmid DNA Revenue Market Share by Type (2025-2030)
Table 27. Global GMP Plasmid DNA Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global GMP Plasmid DNA Revenue Market Share by Application (2019-2024)
Table 29. Global GMP Plasmid DNA Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global GMP Plasmid DNA Revenue Market Share by Application (2025-2030)
Table 31. North America GMP Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America GMP Plasmid DNA Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America GMP Plasmid DNA Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe GMP Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe GMP Plasmid DNA Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe GMP Plasmid DNA Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific GMP Plasmid DNA Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific GMP Plasmid DNA Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific GMP Plasmid DNA Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America GMP Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America GMP Plasmid DNA Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America GMP Plasmid DNA Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa GMP Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa GMP Plasmid DNA Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa GMP Plasmid DNA Market Size by Country (2025-2030) & (US$ Million)
Table 46. Cobra Bio Company Detail
Table 47. Cobra Bio Business Overview
Table 48. Cobra Bio GMP Plasmid DNA Product
Table 49. Cobra Bio Revenue in GMP Plasmid DNA Business (2019-2024) & (US$ Million)
Table 50. Cobra Bio Recent Development
Table 51. Waisman Biomanufacturing Company Detail
Table 52. Waisman Biomanufacturing Business Overview
Table 53. Waisman Biomanufacturing GMP Plasmid DNA Product
Table 54. Waisman Biomanufacturing Revenue in GMP Plasmid DNA Business (2019-2024) & (US$ Million)
Table 55. Waisman Biomanufacturing Recent Development
Table 56. Gedeon Richter Company Detail
Table 57. Gedeon Richter Business Overview
Table 58. Gedeon Richter GMP Plasmid DNA Product
Table 59. Gedeon Richter Revenue in GMP Plasmid DNA Business (2019-2024) & (US$ Million)
Table 60. Gedeon Richter Recent Development
Table 61. Eurogentec Company Detail
Table 62. Eurogentec Business Overview
Table 63. Eurogentec GMP Plasmid DNA Product
Table 64. Eurogentec Revenue in GMP Plasmid DNA Business (2019-2024) & (US$ Million)
Table 65. Eurogentec Recent Development
Table 66. VGXI Company Detail
Table 67. VGXI Business Overview
Table 68. VGXI GMP Plasmid DNA Product
Table 69. VGXI Revenue in GMP Plasmid DNA Business (2019-2024) & (US$ Million)
Table 70. VGXI Recent Development
Table 71. PlasmidFactory Company Detail
Table 72. PlasmidFactory Business Overview
Table 73. PlasmidFactory GMP Plasmid DNA Product
Table 74. PlasmidFactory Revenue in GMP Plasmid DNA Business (2019-2024) & (US$ Million)
Table 75. PlasmidFactory Recent Development
Table 76. Kaneka Company Detail
Table 77. Kaneka Business Overview
Table 78. Kaneka GMP Plasmid DNA Product
Table 79. Kaneka Revenue in GMP Plasmid DNA Business (2019-2024) & (US$ Million)
Table 80. Kaneka Recent Development
Table 81. Delphi Genetics Company Detail
Table 82. Delphi Genetics Business Overview
Table 83. Delphi Genetics GMP Plasmid DNA Product
Table 84. Delphi Genetics Revenue in GMP Plasmid DNA Business (2019-2024) & (US$ Million)
Table 85. Delphi Genetics Recent Development
Table 86. Nature Technology Corporation Company Detail
Table 87. Nature Technology Corporation Business Overview
Table 88. Nature Technology Corporation GMP Plasmid DNA Product
Table 89. Nature Technology Corporation Revenue in GMP Plasmid DNA Business (2019-2024) & (US$ Million)
Table 90. Nature Technology Corporation Recent Development
Table 91. LakePharma Company Detail
Table 92. LakePharma Business Overview
Table 93. LakePharma GMP Plasmid DNA Product
Table 94. LakePharma Revenue in GMP Plasmid DNA Business (2019-2024) & (US$ Million)
Table 95. LakePharma Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global GMP Plasmid DNA Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global GMP Plasmid DNA Market Share by Type: 2023 VS 2030
Figure 3. Standard Features
Figure 4. Ultra-Pure Features
Figure 5. Global GMP Plasmid DNA Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global GMP Plasmid DNA Market Share by Application: 2023 VS 2030
Figure 7. DNA Vaccines Case Studies
Figure 8. Gene Therapy Case Studies
Figure 9. Immunotherapy Case Studies
Figure 10. Others Case Studies
Figure 11. GMP Plasmid DNA Report Years Considered
Figure 12. Global GMP Plasmid DNA Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global GMP Plasmid DNA Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global GMP Plasmid DNA Market Share by Region: 2023 VS 2030
Figure 15. Global GMP Plasmid DNA Market Share by Players in 2023
Figure 16. Global Top GMP Plasmid DNA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Plasmid DNA as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by GMP Plasmid DNA Revenue in 2023
Figure 18. North America GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America GMP Plasmid DNA Market Share by Country (2019-2030)
Figure 20. United States GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe GMP Plasmid DNA Market Share by Country (2019-2030)
Figure 24. Germany GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific GMP Plasmid DNA Market Share by Region (2019-2030)
Figure 32. China GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America GMP Plasmid DNA Market Share by Country (2019-2030)
Figure 40. Mexico GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa GMP Plasmid DNA Market Share by Country (2019-2030)
Figure 44. Turkey GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia GMP Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Cobra Bio Revenue Growth Rate in GMP Plasmid DNA Business (2019-2024)
Figure 47. Waisman Biomanufacturing Revenue Growth Rate in GMP Plasmid DNA Business (2019-2024)
Figure 48. Gedeon Richter Revenue Growth Rate in GMP Plasmid DNA Business (2019-2024)
Figure 49. Eurogentec Revenue Growth Rate in GMP Plasmid DNA Business (2019-2024)
Figure 50. VGXI Revenue Growth Rate in GMP Plasmid DNA Business (2019-2024)
Figure 51. PlasmidFactory Revenue Growth Rate in GMP Plasmid DNA Business (2019-2024)
Figure 52. Kaneka Revenue Growth Rate in GMP Plasmid DNA Business (2019-2024)
Figure 53. Delphi Genetics Revenue Growth Rate in GMP Plasmid DNA Business (2019-2024)
Figure 54. Nature Technology Corporation Revenue Growth Rate in GMP Plasmid DNA Business (2019-2024)
Figure 55. LakePharma Revenue Growth Rate in GMP Plasmid DNA Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
